UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

An overview of the pharmacokinetics, efficacy and safety of liraglutide

Diabetes research and clinical practice, 2012-07, Vol.97 (1), p.27-42

Bode, Bruce

2012

Volltextzugriff (PDF)

The Performance and Usability of a Factory-Calibrated Flash Glucose Monitoring System

Diabetes technology & therapeutics, 2015-11, Vol.17 (11), p.787-794

2015

Volltextzugriff (PDF)

Safety of a Hybrid Closed-Loop Insulin Delivery System in Patients With Type 1 Diabetes

JAMA : the journal of the American Medical Association, 2016-10, Vol.316 (13), p.1407

2016

Volltextzugriff (PDF)

Glycemic Characteristics and Clinical Outcomes of COVID-19 Patients Hospitalized in the United States

Journal of diabetes science and technology, 2020-07, Vol.14 (4), p.813-821

2020

Volltextzugriff (PDF)

Continuous and Intermittent Glucose Monitoring in 2023

Diabetes technology & therapeutics, 2024-03, Vol.26 (S1), p.S14-S-31

2024

Volltextzugriff (PDF)

New Insulin Delivery Recommendations

Mayo Clinic proceedings, 2016-09, Vol.91 (9), p.1231-1255

2016

Volltextzugriff (PDF)

Threshold-Based Insulin-Pump Interruption for Reduction of Hypoglycemia

The New England journal of medicine, 2013-07, Vol.369 (3), p.224-232

2013

Volltextzugriff (PDF)

Continuous and Intermittent Glucose Monitoring in 2022

Diabetes technology & therapeutics, 2023-02, Vol.25 (S1), p.S15-S-29

2023

Volltextzugriff (PDF)

Compatibility and Safety of Ultra Rapid Lispro with Continuous Subcutaneous Insulin Infusion in Patients with Type 1 Diabetes: PRONTO-Pump Study

Diabetes technology & therapeutics, 2021-01, Vol.23 (1), p.41-50

2021

Volltextzugriff (PDF)

Fast-Acting Insulin Aspart Improves Glycemic Control in Basal-Bolus Treatment for Type 1 Diabetes: Results of a 26-Week Multicenter, Active-Controlled, Treat-to-Target, Randomized, Parallel-Group Trial (onset 1)

Diabetes care, 2017-07, Vol.40 (7), p.943-950

2017

Volltextzugriff (PDF)

Sotagliflozin, a Dual SGLT1 and SGLT2 Inhibitor, as Adjunct Therapy to Insulin in Type 1 Diabetes

Diabetes care, 2015-07, Vol.38 (7), p.1181-1188

2015

Volltextzugriff (PDF)

Faster Aspart Versus Insulin Aspart as Part of a Basal-Bolus Regimen in Inadequately Controlled Type 2 Diabetes: The onset 2 Trial

Diabetes care, 2017-07, Vol.40 (7), p.951-957

2017

Volltextzugriff (PDF)

Efficacy and Safety of Liraglutide Added to Insulin Treatment in Type 1 Diabetes: The ADJUNCT ONE Treat-To-Target Randomized Trial

Diabetes care, 2016-10, Vol.39 (10), p.1702-1710

2016

Volltextzugriff (PDF)

Real-time continuous glucose monitoring among participants in the T1D Exchange clinic registry

Diabetes care, 2014-10, Vol.37 (10), p.2702-2709

2014

Volltextzugriff (PDF)

Multicenter Trial of a Tubeless, On-Body Automated Insulin Delivery System With Customizable Glycemic Targets in Pediatric and Adult Participants With Type 1 Diabetes

Diabetes care, 2021-07, Vol.44 (7), p.1630-1640

2021

Volltextzugriff (PDF)

Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults With Type 1 Diabetes: A Randomized Clinical Trial

JAMA : the journal of the American Medical Association, 2020-06, Vol.323 (23), p.2397

2020

Volltextzugriff (PDF)

Continuous and Intermittent Glucose Monitoring in 2021

Diabetes technology & therapeutics, 2022-03, Vol.24 (S1), p.S209-S-219

2022

Volltextzugriff (PDF)

Glucose Outcomes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery System in Adolescents and Adults with Type 1 Diabetes

Diabetes technology & therapeutics, 2017-03, Vol.19 (3), p.155-163

2017

Volltextzugriff (PDF)

Consensus Statement by the American Association of Clinical Endocrinologists/American College of Endocrinology insulin pump management task force

Endocrine practice, 2014-05, Vol.20 (5), p.463-489

2014

Volltextzugriff (PDF)

Continuous and Intermittent Glucose Monitoring in 2020

Diabetes technology & therapeutics, 2021-06, Vol.23 (S2), p.S16-S-31

2021

Volltextzugriff (PDF)

Safety Evaluation of the MiniMed 670G System in Children 7-13 Years of Age with Type 1 Diabetes

Diabetes technology & therapeutics, 2019-01, Vol.21 (1), p.11-19

2019

Volltextzugriff (PDF)

REPLACE-BG: A Randomized Trial Comparing Continuous Glucose Monitoring With and Without Routine Blood Glucose Monitoring in Adults With Well-Controlled Type 1 Diabetes

Diabetes care, 2017-04, Vol.40 (4), p.538-545

2017

Volltextzugriff (PDF)

711-P: Glycemic Outcomes for Adult Type 1 Diabetes (T1D) with and without DKA Treated with an Electronic Glycemic Management System

Diabetes (New York, N.Y.), 2021-06, Vol.70 (Supplement_1)

2021

Volltextzugriff (PDF)

94-LB: IV Insulin via Glucommander, an Electronic Glycemic Management System (eGMS) Demonstrates Low Rates of Hypoglycemia in Patients with Low Glomerular Filtration Rate (GFR) Compared with Other eGMS

Diabetes (New York, N.Y.), 2021-06, Vol.70 (Supplement_1)

2021

Volltextzugriff (PDF)

1 – 25 von 364

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(337)
Mit Volltextzugriff
(287)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(201)
Life Sciences & Biomedicine
(197)
Humans
(190)
Diabetes
(149)
Endocrinology & Metabolism
(142)
Female
(116)
Male
(115)
Adult
(109)
Insulin
(97)
Middle Aged
(90)
Diabetes Mellitus, Type 1 - Drug Therapy
(81)
Diabetes Mellitus, Type 1 - Blood
(72)
Hypoglycemia
(71)
Diabetes Mellitus
(64)
Glucose
(63)
Hypoglycemic Agents - Administration & Dosage
(62)
Aged
(61)
Adolescent
(59)
Hypoglycemic Agents - Therapeutic Use
(56)
Insulin - Administration & Dosage
(56)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(2)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

An overview of the pharmacokinetics, efficacy and safety of liraglutide

The Performance and Usability of a Factory-Calibrated Flash Glucose Monitoring System

Safety of a Hybrid Closed-Loop Insulin Delivery System in Patients With Type 1 Diabetes

Glycemic Characteristics and Clinical Outcomes of COVID-19 Patients Hospitalized in the United States

Continuous and Intermittent Glucose Monitoring in 2023

New Insulin Delivery Recommendations

Threshold-Based Insulin-Pump Interruption for Reduction of Hypoglycemia

Continuous and Intermittent Glucose Monitoring in 2022

Compatibility and Safety of Ultra Rapid Lispro with Continuous Subcutaneous Insulin Infusion in Patients with Type 1 Diabetes: PRONTO-Pump Study

Fast-Acting Insulin Aspart Improves Glycemic Control in Basal-Bolus Treatment for Type 1 Diabetes: Results of a 26-Week Multicenter, Active-Controlled, Treat-to-Target, Randomized, Parallel-Group Trial (onset 1)

Sotagliflozin, a Dual SGLT1 and SGLT2 Inhibitor, as Adjunct Therapy to Insulin in Type 1 Diabetes

Faster Aspart Versus Insulin Aspart as Part of a Basal-Bolus Regimen in Inadequately Controlled Type 2 Diabetes: The onset 2 Trial

Efficacy and Safety of Liraglutide Added to Insulin Treatment in Type 1 Diabetes: The ADJUNCT ONE Treat-To-Target Randomized Trial

Real-time continuous glucose monitoring among participants in the T1D Exchange clinic registry

Multicenter Trial of a Tubeless, On-Body Automated Insulin Delivery System With Customizable Glycemic Targets in Pediatric and Adult Participants With Type 1 Diabetes

Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults With Type 1 Diabetes: A Randomized Clinical Trial

Continuous and Intermittent Glucose Monitoring in 2021

Glucose Outcomes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery System in Adolescents and Adults with Type 1 Diabetes

International Consensus on Risk Management of Diabetic Ketoacidosis in Patients With Type 1 Diabetes Treated With Sodium-Glucose Cotransporter (SGLT) Inhibitors

Consensus Statement by the American Association of Clinical Endocrinologists/American College of Endocrinology insulin pump management task force

Continuous and Intermittent Glucose Monitoring in 2020

Safety Evaluation of the MiniMed 670G System in Children 7-13 Years of Age with Type 1 Diabetes

REPLACE-BG: A Randomized Trial Comparing Continuous Glucose Monitoring With and Without Routine Blood Glucose Monitoring in Adults With Well-Controlled Type 1 Diabetes

711-P: Glycemic Outcomes for Adult Type 1 Diabetes (T1D) with and without DKA Treated with an Electronic Glycemic Management System

94-LB: IV Insulin via Glucommander, an Electronic Glycemic Management System (eGMS) Demonstrates Low Rates of Hypoglycemia in Patients with Low Glomerular Filtration Rate (GFR) Compared with Other eGMS

Suchergebnisse filtern